Zinzino: ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2024
Zinzino group revenue increased with a total of 20 %, compared with the previous year.
The revenue in October for Zinzino's sales markets increased by 20 % and amounted to SEK 190.0 (157.7) million. Faun Pharma's external sales increased by 19 % and amounted to SEK 7.4 (6.2) million. Overall, the Group increased revenues by 20 % to SEK 197.4 (163.9) million compared with the previous year.
Accumulated revenue for January - October 2024 increased by 21 % to SEK 1691.7 (1402.4) million.
Revenues were distributed as follows:
Regions,MSEK 24 23 Change YTD 2024 YTD 2023 Change
-Oct -Oct
The Nordics 28.8 28.6 1% 242.7 245.7 -1%
Central 53.7 41.7 29% 448.1 344.7 30%
Europe
East Europe 34.2 31.2 10% 314,0 312.5 0%
South & West 36.6 26.3 39% 301.1 206.5 46%
Europe
The Baltics 10.1 10,0 1% 79.6 76.8 4%
North 19.4 17.1 13% 153.4 84.9 81%
America
Asia-Pacific 5.5 2.0 175% 53.1 43.0 23%
Africa 1.7 0.8 12.5 10.8 16%
113%
Zinzino 190.0 157.7 20% 1604.5 1324.9 21%
Faun Pharma 7.4 6.2 19% 87.2 77.5 13%
Zinzino 197.4 163.9 20% 1691.7 1402.4 21%
Group
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Carnegie Investment Bank AB (publ)